Literature DB >> 10982026

Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.

S B Potterf1, M Furumura, K J Dunn, H Arnheiter, W J Pavan.   

Abstract

Waardenburg syndrome (WS) is associated with neural crest-derived melanocyte deficiency caused by mutations in either one of three transcription factors: MITF, PAX3, and SOX10. However, the hierarchical relationship of these transcription factors is largely unknown. We show that SOX10 is capable of transactivating the MITF promoter 100-fold, and that this transactivation is further stimulated by PAX3. Promoter deletion and mutational analyses indicate that SOX10 can activate MITF expression through binding to a region that is evolutionarily conserved between the mouse and human MITF promoters. A SOX10 mutant that models C-terminal truncations in WS can reduce wild-type SOX10 induction of MITF, suggesting these mutations may act in a dominant-negative fashion. Our data support a model in which the hypopigmentation in WS, of which these factors have been implicated, results from a disruption in function of the central melanocyte transcription factor MITF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982026     DOI: 10.1007/s004390000328

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  121 in total

Review 1.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development.

Authors:  Y Kamachi; M Uchikawa; A Tanouchi; R Sekido; H Kondoh
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

3.  The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen identified in a patient with a dramatic response to immunotherapy.

Authors:  Hung T Khong; Steven A Rosenberg
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

Review 4.  Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.

Authors:  Ping Wan; Yongqing Hu; Li He
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

Review 5.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

6.  Interspecies difference in the regulation of melanocyte development by SOX10 and MITF.

Authors:  Ling Hou; Heinz Arnheiter; William J Pavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

7.  The Fugu tyrp1 promoter directs specific GFP expression in zebrafish: tools to study the RPE and the neural crest-derived melanophores.

Authors:  Jian Zou; Friedrich Beermann; Jianxin Wang; Koichi Kawakami; Xiangyun Wei
Journal:  Pigment Cell Res       Date:  2006-12

8.  Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.

Authors:  Nadege Bondurand; Florence Dastot-Le Moal; Laure Stanchina; Nathalie Collot; Viviane Baral; Sandrine Marlin; Tania Attie-Bitach; Irina Giurgea; Laurent Skopinski; William Reardon; Annick Toutain; Pierre Sarda; Anis Echaieb; Marilyn Lackmy-Port-Lis; Renaud Touraine; Jeanne Amiel; Michel Goossens; Veronique Pingault
Journal:  Am J Hum Genet       Date:  2007-10-22       Impact factor: 11.025

9.  Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology.

Authors:  Yongqing Liu; Fei Ye; Qiutang Li; Shigeo Tamiya; Douglas S Darling; Henry J Kaplan; Douglas C Dean
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-10       Impact factor: 4.799

10.  Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression.

Authors:  Hung T Khong; Qiong J Wang; Steven A Rosenberg
Journal:  J Immunother       Date:  2004 May-Jun       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.